Share Wealth

Market
  • Markets Navigation
    Company Info.

    Sun Pharmaceutical Industries Ltd.

    Income Statement - Consolidated


    Market Cap.(`) 410130.32 Cr. P/BV 5.93 Book Value (`) 288.06
    52 Week High/Low ( ` ) 1960/1377 FV/ML 1/1 P/E(X) 42.83
    Book Closure 06/02/2025 EPS (`) 39.91 Div Yield (%) 0.79


    (` in Crs.)
    You can view the Consolidated Income Statement for the last 5 years.

    ParticularsMar 24Mar 23Mar 22Mar 21Mar 20
    Months1212121212
    Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
    FaceValue1.001.001.001.001.00
          
          
    INCOME     
    Revenue From Operations [Net]47758.4543278.8738426.4233139.1832325.17
    Other Operating Revenues738.40606.81228.07358.96512.33
    Total Operating Revenues48496.8543885.6838654.4933498.1432837.50
          
    Other Income1354.19634.52921.51835.52635.98
    Total Revenue49851.0444520.2039576.0034333.6633473.48
          
    EXPENSES     
    Cost Of Materials Consumed6904.337777.577049.126153.135515.23
    Purchase Of Stock-In Trade3466.153571.503410.033175.173414.37
    Operating And Direct Expenses630.26561.32557.810.000.00
    Changes In Inventories Of FG,WIP And Stock-In Trade292.13-686.91-107.61-638.22300.85
    Employee Benefit Expenses9429.068296.037300.836862.236362.35
    Finance Costs238.47172.00127.35141.43302.73
    Depreciation And Amortisation Expenses2556.642529.432143.742079.952052.78
    Other Expenses14751.7912719.3810046.599454.4610254.94
    Total Expenses38268.8334940.3230527.8627228.1528203.25
          
    Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax11582.219579.889048.147105.515270.23
          
    Exceptional Items-494.32-171.45-4566.82-4306.14-260.64
    Profit/Loss Before Tax11087.899408.434481.322799.375009.59
          
    Tax Expenses-Continued Operations     
    Current Tax1989.301869.22354.39957.301320.14
    Deferred Tax-549.85-1021.63721.11-442.61-497.34
    Total Tax Expenses1439.45847.591075.50514.69822.80
    Profit/Loss After Tax And Before ExtraOrdinary Items9648.448560.843405.822284.684186.79
          
    Profit/Loss From Continuing Operations9648.448560.843405.822284.684186.79
          
    Profit/Loss For The Period9648.448560.843405.822284.684186.79
          
    Minority Interest-33.65-39.36-116.55631.47-407.03
    Share Of Profit/Loss Of Associates-38.41-47.90-16.54-12.33-14.83
    Consolidated Profit/Loss After MI And Associates9576.388473.583272.732903.823764.93
          
    OTHER INFORMATION     
          
    EARNINGS PER SHARE     
    Basic EPS (Rs.)39.9035.3013.6012.1015.70
    Diluted EPS (Rs.)39.9035.3013.6012.1015.70
          
    DIVIDEND AND DIVIDEND PERCENTAGE     
    Equity Share Dividend2898.162519.302158.911559.061378.96
    Tax On Dividend0.000.000.000.00283.45

  • Sun Pharmaceutical Industries Ltd.

    Balance Sheet - Consolidated


    Market Cap.(`) 410130.32 Cr. P/BV 5.93 Book Value (`) 288.06
    52 Week High/Low ( ` ) 1960/1377 FV/ML 1/1 P/E(X) 42.83
    Book Closure 06/02/2025 EPS (`) 39.91 Div Yield (%) 0.79


    (` in Crs.)
    You can view the Consolidated Balance Sheet for the last 5 years.

    ParticularsMar 24Mar 23Mar 22Mar 21Mar 20
    Months1212121212
    Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
    FaceValue1.001.001.001.001.00
    No. of Equity Shares (in Lacs)23993.3523993.3523993.3523993.3523993.35
          
    EQUITIES AND LIABILITIES     
    SHAREHOLDER'S FUNDS     
    Equity Share Capital239.93239.93239.93239.93239.93
    Total Share Capital239.93239.93239.93239.93239.93
          
    Reserves and Surplus63426.8255755.4547771.2946222.8545024.52
    Total Reserves and Surplus63426.8255755.4547771.2946222.8545024.52
    Total Shareholders Funds63666.7555995.3848011.2246462.7845264.45
    Minority Interest3439.223320.093054.893017.053860.24
          
    NON-CURRENT LIABILITIES     
    Long Term Borrowings1.330.00229.92898.132028.92
    Deferred Tax Liabilities [Net]155.0631.6931.8644.5158.14
    Other Long Term Liabilities802.231146.52902.36771.51823.28
    Long Term Provisions413.89342.91369.07327.12511.00
    Total Non-Current Liabilities1372.511521.121533.212041.273421.34
          
    CURRENT LIABILITIES     
    Short Term Borrowings2844.366197.88700.772444.905549.38
    Trade Payables5653.305681.524479.343973.663583.64
    Other Current Liabilities3129.182673.222872.625144.422737.05
    Short Term Provisions5357.565354.389147.824582.653836.36
    Total Current Liabilities16984.4019907.0017200.5516145.6315706.43
          
    Total Capital And Liabilities85462.8880743.5969799.8767666.7368252.46
          
    ASSETS     
    NON-CURRENT ASSETS     
    Tangible Assets10192.3210390.3810371.3810234.9910567.43
    Intangible Assets4420.115317.035538.915030.355798.02
    Capital Work-In-Progress1107.73963.35797.51936.52658.91
    Intangible Assets Under Development4246.154009.81489.29630.31561.43
    Fixed Assets19966.3120680.5717197.0916832.1717585.79
    Goodwill On Consolidation8598.958712.716549.456287.646481.46
    Non-Current Investments6441.235457.485214.656482.395245.75
    Deferred Tax Assets [Net]4103.653164.242896.723556.443175.29
    Long Term Loans And Advances0.850.610.710.710.79
    Other Non-Current Assets2876.912844.642926.274065.304109.22
    Total Non-Current Assets41987.9040860.2534784.8937224.6536598.30
          
          
    CURRENT ASSETS     
    Current Investments8584.549372.617633.943130.064897.36
    Inventories9868.2910513.058996.818997.027874.99
    Trade Receivables11249.3711438.5110592.899061.409421.24
    Cash And Cash Equivalents10520.685770.295033.356445.516487.55
    Short Term Loans And Advances65.0241.32169.9756.01148.38
    OtherCurrentAssets3187.082747.562588.022752.082824.64
    Total Current Assets43474.9839883.3435014.9830442.0831654.16
          
    Total Assets85462.8880743.5969799.8767666.7368252.46
          
    OTHER INFORMATION     
          
    CONTINGENT LIABILITIES, COMMITMENTS     
    Contingent Liabilities6343.607903.076756.557057.737508.95
          
    BONUS DETAILS     
    Bonus Equity Share Capital183.81183.81183.81183.81183.81
          
    NON-CURRENT INVESTMENTS     
    Non-Current Investments Quoted Market Value5369.244486.914242.705254.104281.38
    Non-Current Investments Unquoted Book Value744.31695.79818.841080.01834.29
          
    CURRENT INVESTMENTS     
    Current Investments Quoted Market Value4198.604934.874031.803099.064493.68
    Current Investments Unquoted Book Value4385.944437.743602.1431.00403.68
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html